Investor Ideas, Trading Ideas and Stocks to Watch : #AIEye #Podcast: #AI #Stocks in the News: (OTCPINK: $GTCH) (NYSE: $JNPR)

Tuesday, July 11, 2023

#AIEye #Podcast: #AI #Stocks in the News: (OTCPINK: $GTCH) (NYSE: $JNPR)

#AIEye #Podcast: #AI #Stocks in the News: (OTCPINK: $GTCH) (NYSE: $JNPR)

GBT Receives Notice of Publication for Sigma Continuation Patent, and Juniper’s Mist AI Deployed by University of Oxford

Global AI-Based Clinical Trial Solutions for Patient Matching Market to Reach $2.87B in 2032

Vancouver, Kelowna, Delta, BC – July 11, 2023 – Investorideas.com, a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye-watching stock news, deal tracker and advancements in artificial intelligence – featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2023/071123-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2023/artificial-intelligence/07111GTCH-JNPR.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (OTCPINK:GTCH) (NYSE:JNPR)

GBT Technologies Inc. (OTC PINK:GTCH) has received a notice of publication for its continuation patent application for automatic correction of Integrated Circuits electrical connectivity mismatches, codenamed “Sigma”. This continuation application aims to enhance and strengthen Sigma's AI technology, “focusing on intelligent systems and methods to automate integrated circuits electrical connectivity errors correction.” According to the press release, the technology’s goal “is to eliminate the manual, tedious, and time-consuming correction task, improving the microchip's overall silicon area, its performance, and electrical characteristics,” and strengthening the AI technology will “enable vast data processing, efficient correction, handling complex area computations, optimization and utilization in a reasonable time.”

Juniper Networks, Inc. (NYSE:JNPR) has announced that numerous departments and colleges of the University of Oxford have deployed Juniper’s cloud-delivered wireless access solution driven by Mist AI™ to provide a modern digital experience to students, faculty, staff and guests. Robert Jones, Oxford’s Managed Network Services Manager, IT Services, said:

"AI-driven networking from Juniper has delivered on the requirement to improve network visibility and control for Oxford’s units subscribing to the Managed Wireless Service, with the tools to resolve issues quickly. The actionable insight provided by Mist AI is phenomenal, enabling us to have better visibility into end-user experiences."

Global AI-Based Clinical Trial Solutions for Patient Matching Market to Reach $2.87B in 2032

A report published by Polaris Market Research finds that the global market for AI-based Clinical Trial Solutions for Patient Matching is projected to grow from $253.13 million USD to $2.87 billion in 2032, registering a compound annual growth rate (CAGR) of 29.2 percent in the forecast period 2023-32. The following excerpt from the report’s description outlines the major factors contributing to the market’s growth:

[The market is] poised for significant growth due to the advancements in AI and machine learning technologies that have paved the way for sophisticated algorithms and tools to analyze large datasets to identify suitable patients for clinical trials. By leveraging factors like demographics, medical history, genetic profiles, and lifestyle information, AI-based solutions can match patients with specific trial criteria accurately and efficiently.

The increasing demand for personalized medicine is driving the growth of the patient-matching market. Personalized medicine aims to provide tailored treatments based on individual characteristics. Clinical trials play a crucial role in developing such therapies. AI-based patient matching solutions can swiftly identify patients with the traits or biomarkers required for a particular trial, aligning with the demand for personalized medicine and accelerating the development of targeted treatments.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

About Investorideas.com - Big Investing Ideas

Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors.

The Investorideas.com podcasts are also available on Apple Podcasts , Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.

Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a paid featured AI stock. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com